• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现吲哚-哌嗪衍生物作为具有促进神经突生长活性和神经保护活性的选择性组蛋白去乙酰化酶6抑制剂。

Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities.

作者信息

Liang Ting, Xie Zhao, Dang Baiyun, Wang Jiayun, Zhang Tongtong, Luan Xiaofa, Lu Tao, Cao Chenyu, Chen Xin

机构信息

Shaanxi Key Labotory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, PR China.

State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.

出版信息

Bioorg Med Chem Lett. 2023 Feb 1;81:129148. doi: 10.1016/j.bmcl.2023.129148. Epub 2023 Jan 21.

DOI:10.1016/j.bmcl.2023.129148
PMID:36690041
Abstract

Novel indole-piperazine derivatives with a hydroxamic acid moiety were designed and synthesized as selective histone deacetylase 6 (HDAC6) inhibitors. In enzymatic assays, all compounds exhibited nanomolar IC values. N-hydroxy-4-((4-(7-methyl-1H-indole-3-carbonyl)piperazin-1-yl)methyl)benzamide, 9c, was the most potent HDAC6 inhibitor (IC, 13.6 nM). In vitro, 9c induced neurite outgrowth of PC12 cells without producing toxic effects, better than Tubastatin A (Tub A). Additionally, 9c demonstrated blatant neuroprotective activity in PC12 cells against HO-induced oxidative damage. In western blot assay, 9c could increase the acetylation of α-tubulin in a dose-dependent manner.

摘要

设计并合成了具有异羟肟酸部分的新型吲哚 - 哌嗪衍生物作为选择性组蛋白去乙酰化酶6(HDAC6)抑制剂。在酶促试验中,所有化合物均表现出纳摩尔级的IC值。N - 羟基 - 4 - ((4 - (7 - 甲基 - 1H - 吲哚 - 3 - 羰基)哌嗪 - 1 - 基)甲基)苯甲酰胺(9c)是最有效的HDAC6抑制剂(IC,13.6 nM)。在体外,9c可诱导PC12细胞的神经突生长且不产生毒性作用,效果优于曲古抑菌素A(Tub A)。此外,9c在PC12细胞中对过氧化氢诱导的氧化损伤表现出明显的神经保护活性。在蛋白质免疫印迹试验中,9c可呈剂量依赖性地增加α - 微管蛋白的乙酰化水平。

相似文献

1
Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities.发现吲哚-哌嗪衍生物作为具有促进神经突生长活性和神经保护活性的选择性组蛋白去乙酰化酶6抑制剂。
Bioorg Med Chem Lett. 2023 Feb 1;81:129148. doi: 10.1016/j.bmcl.2023.129148. Epub 2023 Jan 21.
2
Re-exploration of tetrahydro-β-carboline scaffold: Discovery of selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting and neuroprotective activities.四氢-β-咔啉骨架的重新探索:发现具有促进神经突生长和神经保护活性的选择性组蛋白去乙酰化酶6抑制剂。
Bioorg Med Chem Lett. 2024 Apr 1;102:129670. doi: 10.1016/j.bmcl.2024.129670. Epub 2024 Feb 21.
3
Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors.基于吲哚的羟肟酸衍生物的设计、合成及作为组蛋白去乙酰化酶抑制剂的生物评价。
Eur J Med Chem. 2022 Jan 5;227:113893. doi: 10.1016/j.ejmech.2021.113893. Epub 2021 Oct 2.
4
Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.喹唑啉-4-酮衍生物作为选择性组蛋白去乙酰化酶-6 抑制剂用于治疗阿尔茨海默病。
J Med Chem. 2013 Sep 12;56(17):6775-91. doi: 10.1021/jm400564j. Epub 2013 Aug 16.
5
Synthesis and biological evaluation of novel N-benzyltriazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.新型N-苄基三唑基异羟肟酸酯衍生物作为选择性组蛋白去乙酰化酶6抑制剂的合成及生物学评价
Bioorg Med Chem. 2023 Feb 1;79:117154. doi: 10.1016/j.bmc.2023.117154. Epub 2023 Jan 11.
6
Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.选择性抑制组蛋白去乙酰化酶6可预防肿瘤坏死因子-α诱导的肺内皮细胞屏障破坏和内毒素诱导的肺水肿。
Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L39-47. doi: 10.1152/ajplung.00051.2016. Epub 2016 May 17.
7
MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.甲基化CpG结合蛋白2(MeCP2)缺乏与微管蛋白乙酰化水平降低有关,并且可以使用组蛋白去乙酰化酶6(HDAC6)抑制剂来恢复。
J Mol Med (Berl). 2015 Jan;93(1):63-72. doi: 10.1007/s00109-014-1202-x. Epub 2014 Sep 12.
8
Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.他拉唑他汀,一种选择性组蛋白去乙酰化酶 6 抑制剂,具有抗炎和抗风湿作用。
Int Immunopharmacol. 2013 May;16(1):72-8. doi: 10.1016/j.intimp.2013.03.016. Epub 2013 Mar 27.
9
Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.组蛋白去乙酰化酶 6(HDAC6)去乙酰化酶活性的抑制增加了其与微管的结合,并抑制 MCF-7 细胞中的微管动态不稳定性。
J Biol Chem. 2013 Aug 2;288(31):22516-26. doi: 10.1074/jbc.M113.489328. Epub 2013 Jun 24.
10
Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.在斑马鱼模型中对HDAC1和HDAC6进行体内药理学调节:对帕金森病的治疗意义。
Pharmacol Res. 2016 Jan;103:328-39. doi: 10.1016/j.phrs.2015.11.024. Epub 2015 Dec 3.

引用本文的文献

1
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery-An Updated Review on Their Multifaceted Therapeutic Applications (2020-2024).吲哚衍生物:现代药物发现中的多功能支架-其多方面治疗应用的最新综述(2020-2024 年)。
Molecules. 2024 Oct 9;29(19):4770. doi: 10.3390/molecules29194770.
2
Design, synthesis and antiproliferative evaluation of tetrahydro-β-carboline histone deacetylase inhibitors bearing an aliphatic chain linker.带有脂肪族链连接基的四氢-β-咔啉组蛋白去乙酰化酶抑制剂的设计、合成及抗增殖活性评价
RSC Adv. 2024 Apr 19;14(18):12762-12771. doi: 10.1039/d4ra01672f. eCollection 2024 Apr 16.
3
Design, Synthesis, and Antiproliferative Activity of Selective Histone Deacetylases 6 Inhibitors Containing a Tetrahydropyridopyrimidine Scaffold.
设计、合成及含四氢吡啶并嘧啶骨架的选择性组蛋白去乙酰化酶 6 抑制剂的抗增殖活性。
Molecules. 2023 Oct 29;28(21):7323. doi: 10.3390/molecules28217323.